Masuho Saburi Masao Ogata Yasuhiro Soga Yoshiyuki Kondo Ryo Kurimoto Kazuhito Itani Kazuhiro Kohno Hiroki Uchida Toshiyuki Nakayama
10.3960/jslrt.19031
J Clin Exp Hematop
2020;60(1):17-20.
anaplastic multiple myeloma carfilzomib daratumumab
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/32224561/
Antibodies, Monoclonal / therapeutic use Antineoplastic Agents / therapeutic use Multiple Myeloma / drug therapy Oligopeptides / therapeutic use
Antibodies, Monoclonal / therapeutic use Antineoplastic Agents / therapeutic use Multiple Myeloma / drug therapy Oligopeptides / therapeutic use Case Reports Aged Bone Marrow / drug effects Bone Marrow / pathology Female Humans Multiple Myeloma / blood Multiple Myeloma / diagnosis Plasma Cells / drug effects Plasma Cells / pathology Treatment Outcome Antibodies, Monoclonal Antineoplastic Agents Oligopeptides daratumumab carfilzomib
PMC7187674
32224561
Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma
2020